Safety and Activity of the Highly Specific BTK Inhibitor BGB-3111 in Patients with Indolent and Aggressive Non Hodgkin's Lymphoma
暂无分享,去创建一个
Michael L. Wang | P. Marlton | S. Opat | C. Tam | W. Kim | L. Xue | J. Trotman | W. Lee | Lai Wang | D. Simpson | D. Gottlieb | S. Ro | P. Johnston | J. Muñoz | Jane E. Huang | J. Hilger | G. Cull